VEGFA and acute myeloid leukemia: In this regard, Kellaway et al. have recently shown that t(8;21) AML relapse relies on the specific interplay of the driver mutation with the stem cell program being triggered by aberrant activation of VEGF and IL-5 signalling, most probably provided from the vascular niche [190].